A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
Abroad (travel likely)RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
High-Risk Prostate Cancer
Locations
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California, United States
- James J. Peters VA Medical Center, Bronx, NY, The Bronx, New York, United States
- VA Portland Health Care System, Portland, OR, Portland, Oregon, United States
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States
- South Texas Health Care System, San Antonio, TX, San Antonio, Texas, United States
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States